Our discovery of this potential novel interaction between platelet-derived TSP1, Nrg4, brown fat, and the liver may add a new layer of complexity to our understanding of NASH progression. This evidence concerns the gene THBS1 and metabolic dysfunction-associated steatohepatitis.